drugset / Trial / NCT01634958
Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma
RandomizedParallel-groupQuadruple-blind
Summary
Specific immunotherapy for IgE mediated sensitization to grass pollen 4 concentrations of a modified pollen extract of Phleum pratense are applied to find out the optimum dose.
Timeline
- Start
- 2012-10
- Primary completion
- 2013-04
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DEPIGOID phleum | Other / unclassified | 100 unknown | Subcutaneous |
| Subject | DEPIGOID phleum | Other / unclassified | 1000 unknown | Subcutaneous |
| Subject | DEPIGOID phleum | Other / unclassified | 5000 unknown | Subcutaneous |
| Subject | DEPIGOID phleum | Other / unclassified | 10000 unknown | Subcutaneous |